Skip to main content
  • Email Alerts
  • News
  • Lilly.com
  • Stock Info
    Expand mega menu
    Expand submenu
    Stock Info
    • Stock Quote & Chart
    • Historic Price Lookup
    • Investment Calculator
    • Dividends & Stock Splits
  • Webcasts & Presentations
  • Financials
    Expand mega menu
    Expand submenu
    Financials
    • SEC Filings
    • Annual Reports
    • Quarterly Results
    • Key Ratios
    • Interactive Financials
    • Debt Securities
  • Individual Investors
  • Corporate Governance
    Expand mega menu
    Expand submenu
    Corporate Governance
    • Governance Documents & Committee Charters
    • Committee Composition
    • Board of Directors and Executive Committee
  • Resources
    Expand mega menu
    Expand submenu
    Resources
    • Clinical Development Pipeline
    • Current Medicines
    • Key Facts
    • 2025 Year in Review
    • Sustainability Report
  • Email Alerts
  • News
  • Lilly.com


Two Lilly scientists working in the lab

Investors

Latest News

September 30, 2026

Lilly's EloraTZP (combination of eloralintide and tirzepatide) delivered greater weight loss and A1C reduction vs. tirzepatide 15 mg in adults with obesity and type 2 diabetes

September 30, 2026

New Phase 3b data show Lilly's EBGLYSS (lebrikizumab-lbkz) delivered significant and rapid improvements in skin clearance, itch, pain, and patient satisfaction in people with moderate-to-severe hand and foot atopic dermatitis

September 29, 2026

Lilly's triple agonist, retatrutide, delivered substantial weight loss and A1C reduction, underscoring its potential promise for people with obesity and type 2 diabetes

View All

Upcoming Events

September 30, 2026

European Association for the Study of Diabetes 2026 Annual Meeting

October 29, 2026 at 10:00 AM EDT

Q3 2026 Earnings Call

View All

A Lilly scientist working on medicine discovery

Clinical Development Pipeline

Learn More

Two Lilly employees in a lab checking quarterly results

Quarterly Results

View Results

2025 Year in Review

2025 Year in Review

View This Report

Lilly employees discussing key financial ratios in a conference room

Key Ratios

Key Financial Ratios

Solar panels in a field, representing Lilly's commitment to sustainability

Sustainability Report

Learn More

Three Lilly employees discussing latest developments at Lilly

Latest Sustainability Developments

View Stories

Two Lilly employees in a conversation with a view of Lilly's corporate center in Indianapolis, Indiana in the background

Investor Email Alerts

Sign up to receive email alerts for various types of investor content.

Diversity
Contact
Suppliers
Login
Terms of Use
Privacy Statement
Consumer Health Privacy Notice
Accessibility Statement
Sitemap

To speak to customer support:
Call (800) 545-5979

Your Privacy Choices logo Your Privacy Choices

Cookie Settings

Copyright © 2026 Eli Lilly and Company. All rights reserved.
Twitter Facebook Instagram LinkedIn YouTube
Terms of Use Privacy Statement Consumer Health Privacy Notice Accessibility Statement Sitemap